Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06282978
Status:
RECRUITING
Last Update Posted:
2024-03-06
First Post:
2023-11-23
Brief Title:
Study of Elranatamab for Relapsed or Refractory Myeloma in Patients Previously Exposed to Three-drug Classes
Sponsor:
PETHEMA Foundation
Organization:
PETHEMA Foundation
Organization Data
Organization:
PETHEMA Foundation
Class:
OTHER
Study ID:
GEM-RANTAB
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PETHEMA Foundation
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None